Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2025 07:00 ET | Source: Tisento Therapeutics Inc

Tisento Highlights Two Venues Advancing Patient-Focused Therapeutic Development for Mitochondrial Diseases

Tisento announces upcoming opportunities to optimize therapeutic development for mitochondrial diseases.
January 27, 2025 07:00 ET | Source: Tisento Therapeutics Inc

First Participant Dosed in Tisento Therapeutics’ Global Phase 2b PRIZM Study Evaluating Zagociguat for the Treatment of MELAS

The first patient has been dosed in Tisento's global Phase 2b PRIZM study investigating zagociguat in MELAS.
October 25, 2023 08:00 ET | Source: Tisento Therapeutics Inc

Tisento Therapeutics Initiates Interview Study with Individuals with MELAS to Elucidate the Symptoms and Impact of Disease and Inform the Zagociguat Clinical Development Program

Tisento Therapeutics Initiates Interview Study with Individuals with MELAS to Elucidate the Symptoms and Impact of Disease and Inform the Zagociguat Clinic